CES3 Antibodies

Santa Cruz Biotechnology offers a broad range of CES3 Antibodies for research focused on understanding carboxylesterase 3 (CES3) in various biological processes. CES3 Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carboxylesterase 3 is an important enzyme involved in the metabolism of drugs and xenobiotics, playing a crucial role in the detoxification processes within the liver. CES3 activity significantly influences pharmacokinetics, affecting the efficacy and safety of therapeutic agents. Research into CES3 function provides valuable insights into drug metabolism and potential interactions. Understanding CES3 mechanisms helps advance knowledge in pharmacology and toxicology fields. Investigating CES3 expression patterns can reveal new therapeutic targets and strategies. Exploring CES3 regulation may uncover novel pathways in drug processing and metabolism. Santa Cruz Biotechnology monoclonal antibodies for CES3 research support scientists in making meaningful discoveries that enhance our understanding of drug metabolism and therapeutic development.